Purpose: The laparoscopic mini gastric bypass (LMGB) is purportedly a technically simpler, yet equally effective operation to the laparoscopic Roux‐en‐Y gastric bypass as treatment for morbid obesity. This study reports the early results of LMGB in a major New Zealand bariatric centre.Methodology: Clinical data was prospectively collected on all patients undergoing LMGB over a two year period.Results: 142 patients were studied. 77% were females. Mean age was 43.8. Pre‐operative mean body weight and body mass index (BMI) were 121.3 kg and 45.4 kg/m2 respectively. Mean BMI at one and two years follow up had decreased to 27.35 and 25.72 kg/m2 respectively. 83% of patients reported obesity associated co‐morbidities pre‐operatively. Post‐operatively, 78% of patients reported a reduction in medication requirement. All surgery was performed laparoscopically. There were no anastomotic leaks and zero mortality. 8% of patients required further operations for complications or revision to a Roux‐en‐Y gastric bypass. 20% of patients required subsequent endoscopic interventions, the majority for investigation of vomiting and/or pain. 22% of patients required re‐admission. 14% of patients reported new onset reflux or worsening of pre‐existing reflux after LMGB. 82% of patients reported increased exercise capability post LMGB. 54% of patients required vitamin supplementation.Conclusion: LMGB achieves significant weight loss and resolution of obesity related co‐morbidities with a low short term complication rate. LMGB should be considered as a safe and simple surgical option for morbid obesity.